Vitamins are often sold as a simple promise. Get enough, feel better, and keep going. But vitamin B12 is a reminder that the human body is not a phone battery you can charge past full without asking what else is happening.
Researchers are now looking more closely at B12 because both unusually low intake and unusually high blood levels have appeared in cancer studies. The careful takeaway is not panic over a multivitamin. It is balance, and a better understanding of what an abnormal blood test may be trying to tell doctors.
What B12 does
Vitamin B12, also called cobalamin, helps keep blood and nerve cells healthy and helps the body make DNA, the instruction manual inside nearly every cell. Adults generally need 2.4 micrograms a day, while pregnancy and breastfeeding require slightly more.
The vitamin is found naturally in animal foods, including fish, meat, eggs, milk, and dairy products. Plant foods do not naturally contain B12 unless they are fortified, which is why vegans, some older adults, and people with gut disorders may need supplements or medical testing.
The cancer puzzle
Why would a basic nutrient show up in cancer research at all? One reason is DNA. Cancer begins when cells pick up changes in their DNA, and serious B12 deficiency may interfere with the way cells copy and repair that genetic material.
That does not mean B12 is a cancer drug, or that a shortage automatically leads to cancer. Rima Obeid of Saarland University Hospital reviewed human studies in 2022 and found that the evidence was too inconsistent to say high B12 intake, high blood B12, or B12 treatment directly causes cancer.
A Goldilocks pattern
A Vietnam case-control study added a twist. Ngoan Tran Le and colleagues examined 3,758 cancer cases and 2,995 controls, then reported a U-shaped pattern, meaning cancer risk looked higher at both the low and high ends of dietary B12 intake than in the middle.
That sounds alarming at first, but it needs a careful reading. The study was observational, so it could show a relationship but not prove cause and effect.
Also, the higher-intake group was not taking huge amounts by supplement standards, averaging only about 2.97 micrograms a day in the information reviewed for this article.
Blood tests tell another story
Here is where things get tricky. The amount of B12 a person eats is not the same thing as the amount found in the bloodstream. Blood levels also depend on how the body stores, transports, and releases the vitamin.
The liver stores a large reserve of B12. If cancer affects the liver, spreads aggressively, or changes the proteins that carry B12 through blood, lab results can rise for reasons that have little to do with dinner or a supplement bottle.
In practical terms, the high number may be smoke from a fire, not the match that started it.
A marker, not a verdict
A 2024 systematic review led by Sandra B. Amado-Garzon at Pontificia Universidad Javeriana reported an association between elevated B12 and higher cancer risk, but also warned that the meaning of high B12 in people already diagnosed with cancer remains uncertain and may involve reverse causality.
That means the disease may be pushing B12 levels upward, rather than B12 pushing the disease forward.
The newest colon cancer data points in the same cautious direction. Bruce Chang-Gu and colleagues at the University of Texas Medical Branch studied 37,106 colon cancer patients and found that very high B12 was linked with shorter median survival and more metastasis, or cancer spread.
The authors described elevated B12 as a possible biomarker, which means a measurable clue doctors may use alongside other information, not a stand-alone diagnosis.
What this means now
So should people throw away their B12? No. Deficiency can cause tiredness, weakness, nerve problems, balance issues, and memory trouble, and it should be treated when it is found. For many people, especially those who eat little or no animal food, B12 is not optional.
The more reasonable concern is long-term megadosing without medical advice, or a persistently high B12 blood test in someone who is not taking supplements. That kind of result deserves a conversation with a health professional, not a social media diagnosis.
At the end of the day, the vitamin B12 story is less about fear and more about context. Too little can hurt. Too much in the blood may sometimes be a clue that something else is going on.
The main colon cancer study has been published in Cancer Research Communications.
